Stigma Intervention Among Primary Health Workers in Toronto

July 4, 2017 updated by: Akwatu Khenti, Centre for Addiction and Mental Health

Exploring Stigma, Discrimination, and Recovery-based Perspectives Toward Mental Illness and Substance Use Problems

This project is measuring the effectiveness of an anti-stigma intervention among primary care providers. Both staff and clients will be asked to complete survey data in order to measure the effectiveness. This is a randomized control trial in that three health centres will receive the intervention and three will not. Results will determine if this intervention reduces stigma among staff toward people with a mental health problem and/or substance use problem.

Study Overview

Status

Unknown

Detailed Description

The Office of Transformative Global Health at the Centre for Addiction and Mental Health (CAMH), with funding provided by the Canadian Institutes of Health Research (CIHR), has developed and will be implementing a three year anti-stigma study. This project is a randomized control study which compares the effectiveness of an anti-stigma intervention in three Toronto community health centres. Six centres were selected and randomized so that three receive the intervention and the other three do not. The goal is to determine if the intervention impacts service providers' attitudes and behaviours towards people with mental health problems and addictions. Additionally, the study measures client's perceptions of stigma in order to see if they believe stigma has been reduced or eliminated. The interventions incorporate the following components: innovative contact-based training, raising awareness, recovery-based arts, and a thorough analysis of each centre's policies and procedures.

Innovative contact-based training utilizes an adult education model and focuses on the results of a preliminary situational assessment conducted at each site. Emphasis is placed on concurrent disorders, cultural issues, and inter-professional collaboration. Four three-hour workshops were held at each intervention CHC throughout the project period and included a needs-based curriculum, contact-based education to reduce prejudice and social intolerance, and culturally competent care for vulnerable populations. Raising awareness includes various forms of media such as posters to increase awareness about stigma.

Recovery-based arts was geared towards a local team of leaders who selected one art form for their CHC and were taught by an art expert. Approximately ten service users with a mental health and/or substance abuse problem were invited to participate along with three staff members. After 10 bi-weekly art workshops, staff and clients will showcase their work at each CHC. Finally, an analysis of policies and procedures have been conducted by research staff. This determines what already exists and using an anti-stigma/pro-recovery approach to identify strengths and areas for improvement. Program and policies were studied to identify unintended positive and negative impacts using a modified version of the Health Equity Assessment Tool. Features of the Quality Rights Tool Kit were also used. Recommendations from this process will be developed and shared with each CHC.

Study Type

Interventional

Enrollment (Anticipated)

270

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M2N5E6
        • Centre for Addiction and Mental Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Staff - all staff, no matter their position, is asked to participate.
  • Clients - individuals reporting current or past mental illness and/or substance use problems (MHSUD) AND have received services or participate in any programming at the CHC

Exclusion Criteria:

  • Staff - no exclusion criteria
  • Clients - Clients under the age of 18 years, clients who do not have a MHSUD, or clients that are not safely able to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CHC's given the intervention
Three CHC sites where all staff receive all components of the intervention. Training, Media, Art workshops, and a Policy analysis as well as survey completion.
CHC's NOT given the intervention
No Intervention: CHC's with NO intervention
Three CHC sites where all staff and a selection of clients complete surveys but receive no intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opening Minds Scale for Health Care Providers (OMS-HC)
Time Frame: 2 years
The OMS-HC is a 20-item Canadian scale that was developed specifically to measure stigma among healthcare providers toward individuals with mental illness.This scale has good internal consistency (Cronbach's alpha = 0.82), satisfactory test-retest reliability, intra-class correlation (0.66; 95% CI: 0.54-0.75)59 and sensitivity to change.
2 years
Mental Illness: Clinicians Attitudes Scale (MICA)
Time Frame: 2 years
MICA is a 16-item scale that was also designed to measure attitudes among healthcare workers toward individuals with mental illness.The MICA scale has good internal consistency (Cronbach's alpha = 0.79), with a test-retest reliability (concordance) of 0.80 (95% CI: 0.68-0.91).
2 years
Modified Borgadus Social Distance Scale
Time Frame: 2 years
The Modified Borgadus Social Distance Scale is based on the Borgadus Social Distance Scale.Our study will use a modified six-item version of this scale, focusing specifically on persons with one key mental illness (schizophrenia) and one key addiction (heroin dependence).
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Akwatu A Khenti, MA, Centre for Addiction and Mental Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Anticipated)

March 1, 2018

Study Completion (Anticipated)

March 1, 2018

Study Registration Dates

First Submitted

December 14, 2016

First Submitted That Met QC Criteria

February 2, 2017

First Posted (Estimate)

February 6, 2017

Study Record Updates

Last Update Posted (Actual)

July 6, 2017

Last Update Submitted That Met QC Criteria

July 4, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 0512014

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health Disorder

Clinical Trials on CHC's given the intervention

3
Subscribe